Original articleMetaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding☆
References (36)
- et al.
The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children
J Thorac Cardiovasc Surg
(1989) - et al.
Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters
J Cardiothorac Anesth
(1989) - et al.
Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures
J Cardiothorac Vasc Anesth
(1991) - et al.
Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations?
J Thorac Cardiovasc Surg
(1992) - et al.
The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations
J Thorac Cardiovasc Surg
(1992) - et al.
Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study
J Cardiothorac Vasc Anesth
(1992) - et al.
The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation. A double-blind randomized study
J Thorac Cardiovasc Surg
(1988) - et al.
Prophylactic treatment of postperfusion bleeding using EACA
Chest
(1989) - et al.
Prophylactic tranexamic acid decreases bleeding after cardiac operations
J Thorac Cardiovasc Surg
(1990) - et al.
Effect of aprotinin on need for blood transfusion after repeat open-heart surgery
Lancet
(1987)
Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass
Ann Thorac Surg
(1987)
Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol)
J Thorac Cardiovasc Surg
(1989)
High-dose aprotinin: hemostatic effects in open heart operations
Ann Thorac Surg
(1989)
Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation
J Thorac Cardiovasc Surg
(1991)
Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass
Ann Thorac Surg
(1991)
High-dose aprotinin in cardiac surgery: three years' experience in 1,784 patients
J Cardiothorac Vasc Anesth
(1992)
Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin versus autologous fresh whole blood transfusion
J Cardiothorac Vasc Anesth
(1992)
Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study
Ann Thorac Surg
(1992)
Cited by (213)
Prevention of Ischemic Injury in Cardiac Surgery
2021, Perioperative Medicine: Managing for Outcome, Second EditionPreservation of Renal Function
2021, Perioperative Medicine: Managing for Outcome, Second EditionDesmopressin (DDAVP)
2019, PlateletsMedications for Hemostasis
2019, A Practice of Anesthesia for Infants and ChildrenMedications for Hemostasis
2018, A Practice of Anesthesia for Infants and ChildrenHematologic Problems in the Surgical Patient: Bleeding and Thrombosis
2018, Hematology: Basic Principles and Practice
- ☆
Presented at the Poster Session of the Thirtieth Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 31–Feb 2, 1994.
- 1
Stephen E. Fremes Research and George T. Christakis Research Scholars of the Heart & Stroke Foundation of Ontario.
Copyright © 1994 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.